From Library Journal
Editor of the Medical Technology Stock Letter since the mid-1980s, McCamant uses his experience to provide a broad and deep overview of this exciting juncture of science and commerce. He focuses on why he thinks, from an investor’s perspective, that now is such a propitious time to get into the market. Chapters cover a history of the field, how to invest, a state-of-the-art summary of biotechnology, patents and the clinical review process, and the future of b…
Buy Biotech Investing: Every Investor’s Guide at Amazon